Frontiers in Immunology | Cytokines and Soluble Mediators in Immunity

Review

Published on 24 Jan 2025

IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential

in Cytokines and Soluble Mediators in Immunity

Feiya Sheng
Mi Li
Jia-Mei Yu
Si-Yu Yang
Liang Zou
Guan-Jun Yang
Le-Le Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1533335

1,553 views

Original Research

Published on 23 Jan 2025

The role of CTGF and MFG-E8 in the prognosis assessment of SCAP: a study combining machine learning and nomogram analysis

in Cytokines and Soluble Mediators in Immunity

Tingting Lin
Huimin Wan
Jie Ming
Yifei Liang
Linxin Ran
Jingjing Lu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1446415

899 views

Original Research

Published on 15 Jan 2025

Caspase-1 activation, IL-1/IL-6 signature and IFNγ-induced chemokines in lungs of COVID-19 patients

in Cytokines and Soluble Mediators in Immunity

Audrey Cambon
Christophe Guervilly
Clémence Delteil
Nicola Potere
Richard Bachelier
Edwige Tellier
Evelyne Abdili
Marine Leprince
Marco Giani
Ildo Polidoro

Frontiers in Immunology

doi 10.3389/fimmu.2024.1493306

1,168 views

Original Research

Published on 14 Jan 2025

Terminal complement complex deposition on chondrocytes promotes premature senescence in age- and trauma-related osteoarthritis

in Cytokines and Soluble Mediators in Immunity

Leonie Ruths
Jana Hengge
Graciosa Q. Teixeira
Melanie Haffner-Luntzer
Anita Ignatius
Jana Riegger

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470907

1,237 views

Hypothesis and Theory

Published on 13 Jan 2025

Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation

in Cytokines and Soluble Mediators in Immunity

Rebekah R. Schwartz
Kristina Seiffert-Sinha
Animesh A. Sinha

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500284

683 views

Review

Published on 09 Jan 2025

The role and therapeutic targeting of the CCL2/CCR2 signaling axis in inflammatory and fibrotic diseases

in Cytokines and Soluble Mediators in Immunity

Shan Guo
Qi Zhang
Yingjie Guo
Xiaoyan Yin
Peng Zhang
Tao Mao
Zibin Tian
Xiaoyu Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497026

1,610 views

Original Research

Published on 07 Jan 2025

Analysis of fatty acid-derived lipids in critically ill patients after cardiac surgery yields novel pathophysiologically relevant mediators with possible relevance for systemic inflammatory reactions

in Cytokines and Soluble Mediators in Immunity

Holger Neb
Verena Roth
Jessica Roos
Tom Bauer
Anja Urbschat
Ulrike Heinicke
Carlo Angioni
Dieter Steinhilber
Matthias Piesche
Nerea Ferreirós

Frontiers in Immunology

doi 10.3389/fimmu.2024.1148806

1,432 views

Original Research

Published on 06 Jan 2025

Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection

in Cytokines and Soluble Mediators in Immunity

Juliane Lokau
Yvonne Garbers
Manuel M. Vicente
Anna Dittrich
Stefan Meltendorf
Holger Lingel
Anja K. Münster-Kühnel
Monika Brunner-Weinzierl
Christoph Garbers

Frontiers in Immunology

doi 10.3389/fimmu.2024.1488745

978 views

Review

Published on 03 Jan 2025

Advances in the research of immunomodulatory mechanism of mesenchymal stromal/stem cells on periodontal tissue regeneration

in Cytokines and Soluble Mediators in Immunity

De-Zhi Zhao
Rui-Lin Yang
Han-Xiao Wei
Kang Yang
Yi-Bing Yang
Nuo-Xin Wang
Qian Zhang
Fang Chen
Tao Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1449411

1,715 views

Original Research

Published on 23 Dec 2024

Regulation of human Th9 cell differentiation by lipid modulators targeting PPAR-γ and acetyl-CoA-carboxylase 1

in Cytokines and Soluble Mediators in Immunity

Swetha Peesari
Jeremy P. McAleer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1509408

1,003 views

Original Research

Published on 18 Dec 2024

The landscape of chemokine and cytokine is associated with the distinct clinical status of leprosy patients and their respective household contacts

in Cytokines and Soluble Mediators in Immunity

Lorena Bruna Pereira de Oliveira
Pedro Henrique Ferreira Marçal
Karolina Dias Campos
Daisy Cristina Monteiro dos Santos
Marlucy Rodrigues Lima
Olindo Assis Martins-Filho
Joaquim Pedro Brito-de-Sousa
Thais Abdala-Torres
Roberta Olmo Pinheiro
Euzenir Nunes Sarno

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476450

770 views

Original Research

Published on 18 Dec 2024

High cumulative glucocorticoid dose is associated with increased levels of inflammation-related mediators in active rheumatoid arthritis

in Cytokines and Soluble Mediators in Immunity

Anna Petrackova
Pavel Horak
Jakub Savara
Martina Skacelova
Eva Kriegova

Frontiers in Immunology

doi 10.3389/fimmu.2024.1505615

1,220 views

Original Research

Published on 16 Dec 2024

The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus models

in Cytokines and Soluble Mediators in Immunity

Nassima Bekaddour
Nikaïa Smith
Birgit Caspar
Severine Grinberg
Stephane Giorgiutti
Vincent Rodeschini
Stephanie Dupuy
Nicolas Leboulanger
Darragh Duffy
Pauline Soulas-Sprauel

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490593

1,275 views

Original Research

Published on 11 Dec 2024

PgRNA closely correlates to cytokine profile in HBeAg-positive pregnant women undergoing prophylactic antiviral intervention

in Cytokines and Soluble Mediators in Immunity

Qiao Tang
Chunrui Wang
Hu Li
Zhiwei Chen
Xiaoqing Liu
Yunling Xue
Yue Qiu
Yi Zeng
Peng Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1511855

1,120 views

Clinical Trial

Published on 09 Dec 2024

Evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of SM17 in healthy volunteers: results from pre-clinical models and a first-in-human, randomized, double blinded clinical trial

in Cytokines and Soluble Mediators in Immunity

Guolin Xu
Sabina Paglialunga
Xuchen Qian
Ru Ding
Kenneth Webster
Aernout van Haarst
Caroline Engel
Chin Wai Hui
Lik Hang Lam
Weimin Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495540

1,978 views

Original Research

Published on 06 Dec 2024

Time-dependent variation in immunoparalysis biomarkers among patients with sepsis and critical illness

in Cytokines and Soluble Mediators in Immunity

Abigail Samuelsen
Erik Lehman
Parker Burrows
Anthony S. Bonavia

Frontiers in Immunology

doi 10.3389/fimmu.2024.1498974

809 views